Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | PRKCA | P17252 | 3/20 | 0.33 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.32 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | G6PD | P11413 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.30 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.30 |
| ▸ | HTR1A | P08908 | 1/20 | 0.30 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13674849 | 0.89 | ALDH1A1 (0.33) | ALDH1A1LMNAHSD17B10PRKCA | |
| SCHEMBL8082092 | 0.83 | ALDH1A1 (0.39) | ALDH1A1LMNAHSD17B10PRKCAABCB1 | |
| SCHEMBL4502665 | 0.82 | NAAA (0.33) | ALDH1A1CYP2C19 | |
| SCHEMBL4499475 | 0.81 | TSHR (0.44) | ALDH1A1TSHR | |
| SCHEMBL4510184 | 0.80 | TSHR (0.39) | ALDH1A1HSD17B10SMN1; SMN2TSHRCYP3A4 | |
| SCHEMBL13035886 | 0.78 | — | — | |
| SCHEMBL10349285 | 0.76 | — | — | |
| SCHEMBL13674848 | 0.72 | PRKCA (0.34) | PRKCA | |
| SCHEMBL3462902 | 0.72 | EPHX1 (0.44) | ALDH1A1LMNAHSD17B10PRKCAABCB1 | |
| SCHEMBL25131691 | 0.71 | ALDH1A1 (0.36) | ALDH1A1LMNAHSD17B10PRKCAABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7605276-B2 | Spirocyclic acetal compound and method of producing the same, and polymer having spirocyclic acetal structure | FUJIFILM CORPORATION (JP) | 2009-10-20 | — | — | US | disclosed |
| US-7605276-B2 | Spirocyclic acetal compound and method of producing the same, and polymer having spirocyclic acetal structure | FUJIFILM CORPORATION (JP) | 2009-10-20 | — | — | US | disclosed |
| US-7605276-B2 | Spirocyclic acetal compound and method of producing the same, and polymer having spirocyclic acetal structure | FUJIFILM CORPORATION (JP) | 2009-10-20 | — | — | US | disclosed |
| US-20070191584-A1 | dehydration condensation, in the presence of a solid acid catalyst, formula (I) and pentaerythritol | FUJIFILM CORPORATION (JP) | 2007-08-16 | — | — | US | disclosed |
| US-20070191584-A1 | dehydration condensation, in the presence of a solid acid catalyst, formula (I) and pentaerythritol | FUJIFILM CORPORATION (JP) | 2007-08-16 | — | — | US | disclosed |
| US-20070191584-A1 | dehydration condensation, in the presence of a solid acid catalyst, formula (I) and pentaerythritol | FUJIFILM CORPORATION (JP) | 2007-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070191584-A1 | dehydration condensation, in the presence of a solid acid catalyst, formula (I) and pentaerythritol | CCNL2, PKD1, MRPL21 | ALDH1A1 573/4885LMNA 686/4885HSD17B10 478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.